REQUIREMENTS FOR ELECTRONIC POSTER REPORTS

REQUIREMENTS FOR ELECTRONIC POSTER REPORTS
The 2nd International Biomedical Forum
“International Biomedical Forum: Research and Innovation”
October 22–23, 2026, Karaganda Medical University

1. Subject areas
Electronic poster reports are accepted in the following areas:
Development and Implementation of New Pharmaceuticals
Development of drug molecules, preclinical and clinical research, translational pharmacology, evaluation of efficacy and safety of medicine, new delivery systems, and prospective therapeutic approaches.
OMICs Technologies
Genomics, transcriptomics, proteomics, metabolomics, epigenomics, multi-omic research, molecular biomarkers, and personalized medicine.
Bioinformatics, data analysis, and artificial intelligence in biomedicine
Bioinformatic analysis, medical statistics, machine learning, predictive models, clinical decision support systems, biomedical data processing, and digital healthcare solutions.
Bioengineering and medical technologies
Biomaterials, tissue engineering, medtech, tests, biosensors, medical robotics, telehealth, digital medical devices, and rehabilitation technologies.
Doctoral students and young researchers may submit electronic posters in any of the specified areas.

2. General requirements
Posters that present the following are eligible for submission:
• results of original scientific research;
• results of preclinical or clinical research;
• systematic and analytical reviews;
• clinical cases of scientific or practical significance;
• results of the development of medical technologies, devices, software solutions, or prototypes;
• science-based concepts and interdisciplinary projects.
Submitted materials must correspond to the forum's subject areas, contain science-based findings, and be designed in compliance with the rules of research and publication ethics.

3. Technical format
The electronic poster is drawn up as a single slide.
Main specifications:
• aspect ratio: 16:9, layout: horizontal;
• recommended slide size: 33.867 × 19.05 cm;
• file format: PDF (additionally, the source file in PPTX format may be requested);
• file size: no more than 20 MB;
• all fonts must be displayed correctly without additional installation;
• images must have sufficient resolution and remain clear when displayed on a large screen;
• videos, animation, audio, and automatic transitions are not applied;
• poster should not contain external links required for understanding the main results.
Only one presentation may be included on each poster.

4. Poster structure
The upper section of the electronic poster includes:
- title of the presentation;
- surnames and initials of all authors;
- name of the institution;
- city and country;
- e-mail address of the presenting author;
- organization's logo (if available).
The main body of the poster should include:
- introduction or brief justification of the relevance;
- goal of research;
- materials and methods;
- main results;
- conclusions;
- information on funding.
The following may also be included:
- results and discussion;
- practical recommendations;
- information on research approval by bioethics commission;
- QR code linking to a publication or supplementary materials.

5. Recommended adaptation of the structure
For a clinical case, the following structure is recommended:
• relevance;
• description of a clinical case;
• diagnosis;
• treatment or intervention;
• results;
• discussion;
• conclusion.
For development, technology, or prototype:
• problem;
• proposed solution;
• operating principle or development method;
• results obtained;
• advantages;
• field of practical application;
• readiness level and implementation prospects.

6. Submission requirements
The poster should be visually clear and easy to read when displayed on a screen.
It is recommended to:
- use no more than 2–3 typefaces;
- apply contrasting combination of text and background;
- place information into 3–4 logically connected sections;
- use an integral style for headings, tables, and illustrations;
- prioritize patterns, diagrams, charts, graphs, and images;
- limit the amount of straight text;
- visually highlight the key outcomes and conclusions.
Recommended font sizes:
- presentation title — at least 28 pt;
- information about authors and organizations — at least 18 pt;
- division headings — at least 20 pt;
- text part — at least 16 pt;
- figure and table captions — at least 14 pt.
- the total amount of text should preferably be limited to 500–700 words.

7. Content requirements
The title should breifly and precisely reflect the content of the work.
The objective, methods, results, and conclusions should be logically interconnected.
Conclusions must be supported by the presented results.
All abbreviations should be deciphered when first mentioned.
Tables, graphs, and figures must include titles or explanatory notes.
Numerical results are recommended to be provided with the indication of applied statistical indicators.
It is necessary to indicate the statistical significance of observed differences for comparative research.
Appropriated images or data should be followed by indicating the source.
Placement of personal data or images of patients enabling their identification is not permitted.
When presenting studies involving humans or animals, information regarding approval by bioethics commission should be provided whenever such approval was required.
Trade names are permitted only when scientifically justified. The material must not have an advertising nature.

8. Poster language
Electronic posters can be prepared in:
 Kazakh;
 Russian;
 English.
For posters prepared in Kazakh or Russian, it is additionally recommended to provide the following information in English:
 presentation title;
 authors' surnames and affiliations;
 key conclusions.

9. Poster presentation
Electronic posters are displayed on multimedia screens according to the forum's program.
The presenting author should be present during the poster session and briefly present the work:
- poster presentation — up to 3 minutes;
- answers to questions — up to 2 minutes.
During the presentation, an author uses only the electronic poster submitted in advance. Additional slides are not permitted.

10. Submission of materials
The electronic poster is submitted to the Organizing Committee at conference.kmu@gmail.com by September 15, 2026.
File name: FirstAuthorSurname_ShortTitle_Area.pdf
Example: Ivanov_StrokeBiomarkers_OMICs.pdf
The electronic version must be the final version and fully correspond to the material that will be presented at the forum. Replacement of the file after the submission deadline is permitted only upon agreement with the Organizing Committee.

11. Formal review and eligibility
The materials undergo preliminary examination by the forum's scientific committee, and the selection of reports in conducted.
Grounds for rejection can be:
• discrepancy with the forum areas;
• lack of scientific or practical significance;
• absence of results or well-founded conclusions;
• violation of research or publication ethics rules;
• unreliable or inaccurate presentation of data;
• distinct advertising nature;
• non-compliance with the technical specifications;
• submission after the established deadline.
The Scientific Committee has the right to recommend authors to modify or identify another subject area of a poster.

12. Evaluation
The following are taken into account in the competitive assessment:

Criterion	Points
Relevance and scientific significance	15
Novelty of the research or development	15
Methodological validity	15
Authenticity and quality of presentation of the results	20
Conformity of conclusions with the attained results	10
Practical or translational significance	10
Quality of visual design	10
Presentation and responses to questions	5
Total	100